# Cerus Corp earnings and product outlook

> Live situation record from CLSTR: https://clstr.news/situations/cerus-corp-earnings-and-product-outlook
> Updated: 2026-08-04T11:00:21.000Z. Sources: 5. Developments: 2.

Cerus Corporation reported second‑quarter 2026 results that met analysts' expectations, posting earnings per share of $0.01 on revenue of $63.3 million. Product revenue rose 10% to $57.4 million, driving a 16% year‑over‑year increase in first‑half revenue. The company lifted the low end of its 2026 product‑revenue guidance to $229‑$231 million and raised the outlook for its INTERCEPT fibrinogen complex (IFC) revenue to $23‑$25 million after a 40% surge. Cerus refinanced debt, cutting a term loan by $30 million and targeting up to $3.5 million in annual interest‑expense savings. Adjusted EBITDA remained positive for the ninth consecutive quarter, and management indicated a path to GAAP profitability. The firm submitted an INT200 platelet PMA to the FDA, expecting possible approval in early 2027, and anticipates Phase III INTERCEPT red‑blood‑cell trial results in the fourth quarter. Additionally, Cerus expanded its BARDA contract by nearly $22 million to support U.S. regulatory activities.

## Timeline

### 2026-08-04: Sarepta Therapeutics Reports Q2 Revenue Decline and Revised Outlook

Sarepta Therapeutics posted a 34% revenue drop to $401 M and narrowed its 2026 outlook, while PACS Group, CrossAmerica Partners, Certara and Pacific Biosciences each released Q2 2026 earnings with mixed results

5 sources. https://clstr.news/cluster/certara-posts-q2-loss-reaffirms-revenue-guidance-and-expands-sharebuyback

### 2026-07-30: Cerus Corp posts Q2 2026 earnings in line with expectations and lifts revenue outlook

Cerus Corp's Q2 2026 earnings matched forecasts, with $63.3 M revenue, raised 2026 guidance, IFC revenue outlook uplift, debt refinance, and expanded BARDA contract.

2 sources. https://clstr.news/cluster/cerus-corp-posts-q2-2026-earnings-in-line-with-expectations-and-lifts-revenue-outlook

---
Cite as: Cerus Corp earnings and product outlook. CLSTR, https://clstr.news/situations/cerus-corp-earnings-and-product-outlook